Lymph node trafficking and antigen presentation by endobronchial eosinophils

Journal of Clinical Investigation

Volumn 105, Issue 7, 2000, Pages 945-953

  Shi, Huan Zhong ^a   Humbles, Alison ^b   Gerard, Craig ^b   Jin, Zhuang ^a   Weller, Peter F ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; EOSINOPHIL; IMMUNE RESPONSE; LUNG LYMPH; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034086376     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8945     Document Type: Article

References (41)

1. Seminario, M.C., and Gleich, G.J. 1994. The role of eosinophils in the pathogenesis of asthma. Curr. Opin. Immunol. 6:860-864.
2. Foster, P.S., Hogan, S.P., Ramsay, A.J., Matthaei, K.I., and Young, I.G. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
3. + T cells. J. Exp. Med. 177:573-576.
4. Bentley, A.M., et al. 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8:35-42.
5. Ohkawara, Y., et al. 1996. CD40 expression by human peripheral blood eosinophils. J. Clin. Invest. 97:1761 1766.
6. Woerly, G., et al. 1999. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type I cytokines (interleukin 2 and interferon γ): inhibition by immunoglobulin A complexes. J. Exp. Med. 190:487-495.
7. Lucey, D.R., Nicholson-Weller, A., and Weller, P.F. 1989. Mature human eosinophils have the capacity to express HLA-DR. Proc. Natl. Acad. Sci. USA. 86:1348-1351.
8. Lacy, P., and Moqbel, R. 1997. Eokines: synthesis, storage and release from human eosinophils. Mem. Inst. Oswaldo Cruz 92(Suppl.):H125-H133.
9. Weller, P.F., et al. 1993. Accessory cell function of human eosinophils: HLA-DR dependent, MHC-restricted antigen-presentation and interleukin-1a formation. J. Immunol. 150:2554 2562.
10. Del Pozo, V., et al. 1992. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing. Eur. J. Immunol. 22:1919-1925.
11. Pin, I., et al. 1992. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am. Rev. Respir. Dis. 145:1265-1269.
12. Foresi, A., et al. 1997. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness. J. Allergy Clin. Immunol. 100:58-64.
13. Hansel, T.T., et al. 1991. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin. Exp. Immunol. 86:271-277.
14. Sedgwick, J.B., et al. 1992. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J. Immunol. 149:3710-3718.
15. Mengelers, H.J., et al. 1994. Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics. Am. J. Respir. Crit. Care Med. 149:345-351.
16. Laberge, S., et al. 1997. Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma. Am. J. Respir. Cell Mol. Biol. 17:193-202.
17. Stellato, C., et al. 1995. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J. Immunol. 155:410-418.
18. Rothenberg, M.E. 1999. Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. Am. J. Respir. Cell Mol. Biol. 21:291-295.
19. Taguchi, M., et al. 1998. Patterns for RANTES secretion and intercellular adhesion molecule 1 expression mediate transepithelial T cell traffic based on analyses in vitro and in vivo. J. Exp. Med. 187:1927-1940.
20. Tominaga, A., et al. 1991. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J. Exp. Med. 173:429-437.
21. Hansel, T.T., et al. 1992. Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR. J. Immunol. 149:2130-2136.
22. Tamura, N., et al. 1996. Requirement of CD80 and CD86 molecules for antigen presentation by eosinophils. Scand. J. Immunol. 44:229-238.
23. + T cells. Immunol. Rev. 165:231-247.
24. Persson, C.G. 1997. Centennial notions of asthma as an eosinophilic, desquamative, exudative, and steroid-sensitive disease. Lancet. 350:1021-1024.
25. Resnick, M.B., et al. 1995. Human eosinophils migrate across an intestinal epithelium in response to platelet-activating factor. Gastroenterology. 108:409-416.
26. + T-cell proliferation. Immunology. 81:584-591.
27. Wyss-Coray, T., et al. 1993. Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones. Eur. J. Immunol. 23:3350-3357.
28. Rytömma, T. 1960. Organ distribution and histochemical properties of eosinophil granulocytes in the rat. Acta Pathol. Microbiol. Scand. 50(Suppl.):1-118.
29. Harmsen, A.G., Muggenburg, B.A., Snipes, M.B., and Bice, D.E. 1985. The role of macrophages in particle translocation from lungs to lymph nodes. Science. 230:1277-1280.
30. Havenith, C.E., van Miert, P.P., Breedijk, A.J., Beelen, R.H., and Hoefsmit, E.C. 1993. Migration of dendritic cells into the draining lymph nodes of the lung after intratracheal instillation. Am. J. Respir. Cell Mol. Biol. 9:484-488.
31. Xia, W., Pinto, C.E., and Kradin, R.L. 1995. The antigen-presenting activities of 1a+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen. J. Exp. Med. 181:1275-1283.
32. Crowley, M., Inaba, K., and Steinman, R.M. 1990. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J. Exp. Med. 383-386.
33. MacLean, J.A., et al. 1996. Sequestration of inhaled particulate antigens by lung phagocytes. A mechanism for the effective inhibition of pulmonary cell-mediated immunity. Am. J. Pathol. 148:657-666.
34. Holt, P.G., et al. 1993. Down regulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177:397-407.
35. van Rooijen, N. 1990. Antigen processing and presentation in vivo: the microenvironment as a crucial facror. Immunol. Today. 11:436-439.
36. Platt-Mills, T.A.E. 1992. Mechanisms of bronchial reactivity: the role of immunoglobulin E. Am. Rev. Respir. Dis. 145:S44-S47.
37. van Rooijen, N. 1992. Macrophages as accessory cells in the in vivo humoral immune response: from processing of particulate antigens to regulation by suppression. Semin. Immunol. 4:237-245.
38. Chelen, C.J., et al. 1995. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J. Clin. Invest. 95:1415-1421.
39. Weller, P.F. 1991. The immunobiology of eosinophils. N. Engl. J. Med. 324:1110-1118.
40. Maurer, D., et al. 1995. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J. Immunol. 154:6285-6290.
41. Gosselin, E.J., et al. 1992. Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens. J. Immunol. 149:3477-3481.